Steven Cohen's GPCR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 407,700 shares of Structure Therapeutics Inc. (GPCR) worth $11.42 M, representing 0.02% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in GPCR, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 870,589 shares. Largest reduction occurred in Q4 2024, reducing 761,570 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Structure Therapeutics (GPCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Structure Therapeutics (GPCR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +349,862 | New Buy | 349,862 | $23.79 |
| Q2 2023 | +81,138 | Add 23.19% | 431,000 | $41.57 |
| Q3 2023 | +316,100 | Add 73.34% | 747,100 | $50.42 |
| Q4 2023 | -747,100 | Sold Out | 0 | $0.00 |
| Q2 2024 | +367,679 | New Buy | 367,679 | $39.27 |
| Q3 2024 | +870,589 | Add 236.78% | 1.24 M | $43.89 |
| Q4 2024 | -761,570 | Reduce 61.50% | 476,698 | $27.12 |
| Q1 2025 | -247,267 | Reduce 51.87% | 229,431 | $17.31 |
| Q2 2025 | +100,569 | Add 43.83% | 330,000 | $20.74 |
| Q3 2025 | +77,700 | Add 23.55% | 407,700 | $28.00 |
Steven Cohen's Structure Therapeutics Investment FAQs
Steven Cohen first purchased Structure Therapeutics Inc. (GPCR) in Q1 2023, acquiring 349,862 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Structure Therapeutics Inc. (GPCR) for 10 quarters since Q1 2023.
Steven Cohen's largest addition to Structure Therapeutics Inc. (GPCR) was in Q3 2024, adding 1,238,268 shares worth $54.35 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 407,700 shares of Structure Therapeutics Inc. (GPCR), valued at approximately $11.42 M.
As of the Q3 2025 filing, Structure Therapeutics Inc. (GPCR) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Structure Therapeutics Inc. (GPCR) was 1,238,268 shares, as reported at the end of Q3 2024.